ShiraTronics
BROOKLYN CENTER, MN · Biotechnology · 50 employees
ShiraTronics is working to develop new innovative therapies to combat debilitating chronic migraine headache. We are focused on commercializing novel neuromodulation technologies for this large unmet clinical need.
Funding history
- Series Venture - Series Unknown — $41.7M — Sep 2024
- Series Venture - Series Unknown — $41.7M — Aug 2023
- Series Venture - Series Unknown — $14.9M — Mar 2020
- Series Venture - Series Unknown — $13.7M — Nov 2019
Recent signals
- Sep 30, 2024: Raised $41.7M in Series Venture - Series Unknown
- Aug 11, 2023: Raised $41.7M in Series Venture - Series Unknown
- Mar 27, 2020: Raised $14.9M in Series Venture - Series Unknown
- Nov 05, 2019: Raised $13.7M in Series Venture - Series Unknown
See plans & pricing → Track ShiraTronics’s funding, hiring, and signals — with verified contacts — on Fundz.